Ginseng total saponins reverse corticosterone-induced changes in depression-like behavior and hippocampal plasticity-related proteins by interfering with GSK-3 β -CREB signaling pathway

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Chen, Lin ^a   Dai, Jianguo ^a   Wang, Zhongli ^a   Zhang, Huiyu ^a   Huang, Yufang ^a   Zhao, Yunan ^a  

^a NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GINSENG TOTAL SAPONIN; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; NEUROFILAMENT L PROTEIN; NEUROFILAMENT PROTEIN; PHOSPHOR CYCLIC AMP RESPONSE ELEMENT BINDING PROTEIN; SAPONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; FORCED SWIM TEST; GINSENG; HIPPOCAMPUS; HYPERCORTISOLISM; IMMOBILITY; LOCOMOTION; MALE; MOUSE; MUSCLE STRENGTH; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TAIL SUSPENSION TEST; TREATMENT DURATION;

EID: 84893184373     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/506735     Document Type: Article

References (52)

1. Nocerino E., Amato M., Izzo A. A., The aphrodisiac and adaptogenic properties of ginseng. Fitoterapia 2000 71 supplement 1 S1 S5 2-s2.0-0034255413 10.1016/S0367-326X(00)00170-2 (Pubitemid 30621688)
2. Christensen L. P., Ginsenosides: chemistry, biosynthesis, analysis, and potential health effects. Advances in Food and Nutrition Research 2008 55 1 99 2-s2.0-50349101675 10.1016/S1043-4526(08)00401-4
3. Wang Z., Dai J., Chen L., Huang Y., Zhao Y., Preventive effects of panax ginseng on neuron damage induced by hypercortisolism. Chinese Journal of Experimental Traditional Medical Formulae 2010 16 16 94 98
4. Wang Z., Dai J., Chen L., Huang Y., Zhao Y., Preventive action of panax ginseng roots in hypercortisolism-induced impairment of hippocampal neurons in male C57BL/6N mice. Phytotherapy Research 2011 25 8 1242 1245 2-s2.0-80051685848 10.1002/ptr.3389
5. Jiang B., Xiong Z., Yang J., Antidepressant-like effects of ginsenoside Rg1 are due to activation of the BDNF signaling pathway and neurogenesis in the hippocampus. British Journal of Pharmacology 2012 166 6 1872 1887
6. Dang H., Chen Y., Liu X., Wang Q., Wang L., Jia W., Wang Y., Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009 33 8 1417 1424 2-s2.0-71549173390 10.1016/j.pnpbp.2009.07.020
7. Liu L., Luo Y., Zhang R., Guo J., Effects of ginsenosides on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor in rats exposed to chronic unpredictable mild stress. Zhongguo Zhong Yao Za Zhi 2011 36 10 1342 1347 2-s2.0-80051514403 10.4268/cjcmm20111021
8. Lee S. H., Jung B. H., Kim S. Y., Lee E. H., Chung B. C., The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. Pharmacological Research 2006 54 1 46 49 2-s2.0-33744944294 10.1016/j.phrs.2006.02.001 (Pubitemid 43850822)
9. Einat H., Chronic oral administration of ginseng extract results in behavioral change but has no effects in mice models of affective and anxiety disorders. Phytotherapy Research 2007 21 1 62 66 2-s2.0-33846604092 10.1002/ptr.2024 (Pubitemid 46173911)
10. Chan W. K., Yabe J. T., Pimenta A. F., Ortiz D., Shea T. B., Neurofilaments can undergo axonal transport and cytoskeletal incorporation in a discontinuous manner. Cell Motility and the Cytoskeleton 2005 62 3 166 179 2-s2.0-27644584853 10.1002/cm.20089 (Pubitemid 41572700)
11. Yoshii A., Constantine-Paton M., Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity, and disease. Developmental Neurobiology 2010 70 5 304 322 2-s2.0-77949754231 10.1002/dneu.20765
12. Lipsky R. H., Marini A. M., Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Annals of the New York Academy of Sciences 2007 1122 130 143 2-s2.0-37049030994 10.1196/annals.1403.009 (Pubitemid 350249544)
13. Minichiello L., TrkB signalling pathways in LTP and learning. Nature Reviews Neuroscience 2009 10 12 850 860 2-s2.0-70450196195 10.1038/nrn2738
14. Schmidt H. D., Duman R. S., The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior. Behavioural Pharmacology 2007 18 5-6 391 418 2-s2.0-34548395111 10.1097/FBP.0b013e3282ee2aa8 (Pubitemid 47356367)
15. Conti A. C., Cryan J. F., Dalvi A., Lucki I., Blendy J. A., cAMP response element-binding protein is essential for the upregulation of brain-derived neurotrophic factor transcription, but not the behavioral or endocrine responses to antidepressant drugs. Journal of Neuroscience 2002 22 8 3262 3268 2-s2.0-0037092432 (Pubitemid 35379213)
16. Blendy J. A., The role of CREB in depression and antidepressant treatment. Biological Psychiatry 2006 59 12 1144 1150 2-s2.0-33745222513 10.1016/j.biopsych.2005.11.003
17. Zhao H., Li Q., Zhang Z., Pei X., Wang J., Li Y., Long-term ginsenoside consumption prevents memory loss in aged SAMP8 mice by decreasing oxidative stress and up-regulating the plasticity-related proteins in hippocampus. Brain Research 2009 1256 111 122 2-s2.0-59649100816 10.1016/j.brainres.2008.12.031
18. Zhao H., Li Q., Pei X., Zhang Z., Yang R., Wang J., Li Y., Long-term ginsenoside administration prevents memory impairment in aged C57BL/6J mice by up-regulating the synaptic plasticity-related proteins in hippocampus. Behavioural Brain Research 2009 201 2 311 317 2-s2.0-67349199183 10.1016/j.bbr.2009.03.002
19. Grimes C. A., Jope R. S., Creb DNA binding activity is inhibited by glycogen synthase kinase-3 β and facilitated by lithium. Journal of Neurochemistry 2001 78 6 1219 1232 2-s2.0-0034806590 10.1046/j.1471-4159.2001. 00495.x (Pubitemid 32899754)
20. Tullai J. W., Chen J., Schaffer M. E., Kamenetsky E., Kasif S., Cooper G. M., Glycogen synthase kinase-3 represses cyclic AMP Response element-binding protein (CREB)-targeted Immediate early genes in quiescent cells. Journal of Biological Chemistry 2007 282 13 9482 9491 2-s2.0-34248163605 10.1074/jbc.M700067200 (Pubitemid 47104620)
21. Li X., Jope R. S., Is glycogen synthase kinase-3 a central modulator in mood regulation? Neuropsychopharmacology 2010 35 11 2143 2154 2-s2.0-78651312903 10.1038/npp.2010.105
22. Jope R. S., Johnson G. V. W., The glamour and gloom of glycogen synthase kinase-3. Trends in Biochemical Sciences 2004 29 2 95 102 2-s2.0-0442276554 10.1016/j.tibs.2003.12.004 (Pubitemid 38186580)
23. Klein P. S., Melton D. A., A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Sciences of the United States of America 1996 93 16 8455 8459 2-s2.0-0029776032 10.1073/pnas.93.16.8455 (Pubitemid 26269579)
24. Gould T. D., Einat H., Bhat R., Manji H. K., AR-A014418, a selective GSK-3 inhibitor, produces antidepressant-like effects in the forced swim test. International Journal of Neuropsychopharmacology 2004 7 4 387 390 2-s2.0-10644255687 10.1017/S1461145704004535 (Pubitemid 39648068)
25. Kaidanovich-Beilin O., Milman A., Weizman A., Pick C. G., Eldar-Finkelman H., Rapid antidepressive-like activity of specific glycogen synthase kinase-3 inhibitor and its effect on β -catenin in mouse hippocampus. Biological Psychiatry 2004 55 8 781 784 2-s2.0-1842420631 10.1016/j.biopsych.2004.01.008 (Pubitemid 38429867)
26. Shapira M., Licht A., Milman A., Pick C. G., Shohami E., Eldar-Finkelman H., Role of glycogen synthase kinase-3 β in early depressive behavior induced by mild traumatic brain injury. Molecular and Cellular Neuroscience 2007 34 4 571 577 2-s2.0-33947603193 10.1016/j.mcn.2006.12.006 (Pubitemid 46483079)
27. Wada A., Lithium and neuropsychiatric therapeutics: neuroplasticity via glycogen synthase kinase-3 β β -catenin, and neurotrophin cascades. Journal of Pharmacological Sciences 2009 110 1 14 28 2-s2.0-66349125663 10.1254/jphs.09R02CR
28. Silva R., Mesquita A. R., Bessa J., Sousa J. C., Sotiropoulos I., Leão P., Almeida O. F. X., Sousa N., Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3 β Neuroscience 2008 152 3 656 669 2-s2.0-40949125640 10.1016/j.neuroscience.2007.12.026
29. Oh D. H., Park Y. C., Kim S. H., Increased glycogen synthase kinase-3 β mRNA level in the hippocampus of patients with major depression: a study using the stanley neuropathology consortium integrative database. Psychiatry Investigation 2010 7 3 202 207 2-s2.0-77957724723 10.4306/pi.2010.7.3.202
30. Zhang K., Song X., Xu Y., Continuous GSK-3beta overexpression in the hippocampal dentate gyrus induces prodepressant-like effects and increases sensitivity to chronic mild stress in mice. Journal of Affective Disorders 2013 146 1 45 52 10.1016/j.jad.2012.08.033
31. O'Brien W. T., Harper A. D., Jové F., Woodgett J. R., Maretto S., Piccolo S., Klein P. S., Glycogen synthase kinase-3 β haploinsufficiency mimics the behavioral and molecular effects of lithium. Journal of Neuroscience 2004 24 30 6791 6798 2-s2.0-3342955475 10.1523/JNEUROSCI.4753-03.2004 (Pubitemid 38993901)
32. Bersudsky Y., Shaldubina A., Kozlovsky N., Woodgett J. R., Agam G., Belmaker R. H., Glycogen synthase kinase-3 β heterozygote knockout mice as a model of findings in postmortem schizophrenia brain or as a model of behaviors mimicking lithium action: negative results. Behavioural Pharmacology 2008 19 3 217 224 2-s2.0-42949169723 10.1097/FBP.0b013e3282feb099 (Pubitemid 351670402)
33. Zhao R., Zhang Z., Song Y., Wang D., Qi J., Wen S., Implication of phosphatidylinositol-3 kinase/Akt/glycogen synthase kinase-3 β pathway in ginsenoside Rb1's attenuation of beta-amyloid-induced neurotoxicity and tau phosphorylation. Journal of Ethnopharmacology 2011 133 3 1109 1116 2-s2.0-79551543865 10.1016/j.jep.2010.11.054
34. Zhao H. H., Di J., Liu W. S., Liu H. L., Lai H., Lu Y. L., Involvement of GSK3 and PP2A in ginsenoside Rb1's attenuation of aluminum-induced tau hyperphosphorylation. Behavioural Brain Research 2013 241 228 234 10.1016/j.bbr.2012.11.037
35. China Pharmacopoeia Committee, China Pharmacopoeia 2010 1 Beijing, China China Medical Science Press
36. Gao S. L., Wang H., Technique on extraction and content determination of saponin from Momordica Grosvenori. Natural Product Research and Development 2001 13 36 40
37. Porsolt R. D., Le Pichon M., Jalfre M., Depression: a new animal model sensitive to antidepressant treatments. Nature 1977 266 5604 730 732 2-s2.0-0017618768 (Pubitemid 8073804)
38. Steru L., Chermat R., Thierry B., Simon P., The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985 85 3 367 370 2-s2.0-0021990491 (Pubitemid 15123115)
39. Willner P., Validity, reliability and utility of the chronic mild stress model of depression: a 10-year review and evaluation. Psychopharmacology 1997 134 4 319 329 2-s2.0-0031440325 10.1007/s002130050456 (Pubitemid 28023396)
40. Gregus A., Wintink A. J., Davis A. C., Kalynchuk L. E., Effect of repeated corticosterone injections and restraint stress on anxiety and depression-like behavior in male rats. Behavioural Brain Research 2005 156 1 105 114 2-s2.0-4944259878 10.1016/j.bbr.2004.05.013 (Pubitemid 39330441)
41. Johnson S. A., Fournier N. M., Kalynchuk L. E., Effect of different doses of corticosterone on depression-like behavior and HPA axis responses to a novel stressor. Behavioural Brain Research 2006 168 2 280 288 2-s2.0-32044432128 10.1016/j.bbr.2005.11.019 (Pubitemid 43201945)
42. Zhao Y., Ma R., Shen J., Su H., Xing D., Du L., A mouse model of depression induced by repeated corticosterone injections. European Journal of Pharmacology 2008 581 1-2 113 120 2-s2.0-38549098646 10.1016/j.ejphar.2007.12. 005
43. Marks W., Fournier N. M., Kalynchuk L. E., Repeated exposure to corticosterone increases depression-like behavior in two different versions of the forced swim test without altering nonspecific locomotor activity or muscle strength. Physiology and Behavior 2009 98 1-2 67 72 2-s2.0-67649476121 10.1016/j.physbeh.2009.04.014
44. Gourley S. L., Taylor J. R., Recapitulation and reversal of a persistent depression-like syndrome in rodents. Current Protocols in Neuroscience 2009 49 9.32.1 9.32.11 2-s2.0-75749137310 10.1002/0471142301.ns0932s49
45. Vidal R., Pilar-Cuéllar F., dos Anjos S., Linge R., Treceño B., Vargas V. I., Rodriguez-Gaztelumendi A., Mostany R., Castro E., Diaz A., Valdizán E. M., Pazos A., New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways. Current Pharmaceutical Design 2011 17 5 521 533 2-s2.0-79953316428 10.2174/ 138161211795164086
46. Castren E., Voikar V., Rantamaki T., Role of neurotrophic factors in depression. Current Opinion in Pharmacology 2007 7 1 18 21 10.1016/j.coph.2006. 08.009 (Pubitemid 46238033)
47. Alfonso J., Frick L. R., Silberman D. M., Palumbo M. L., Genaro A. M., Frasch A. C., Regulation of hippocampal gene expression is conserved in two species subjected to different stressors and antidepressant treatments. Biological Psychiatry 2006 59 3 244 251 2-s2.0-32144437619 10.1016/j.biopsych. 2005.06.036 (Pubitemid 43208971)
48. Song L., Che W., Min-wei W., Murakami Y., Matsumoto K., Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacology Biochemistry and Behavior 2006 83 2 186 193 2-s2.0-33646048297 10.1016/j.pbb.2006.01.004
49. Lai I.-C., Hong C.-J., Tsai S.-J., Expression of cAMP response element-binding protein in major depression before and after antidepressant treatment. Neuropsychobiology 2003 48 4 182 185 2-s2.0-0348010581 10.1159/000074635 (Pubitemid 37548224)
50. Yamada S., Yamamoto M., Ozawa H., Riederer P., Saito T., Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. Journal of Neural Transmission 2003 110 6 671 680 2-s2.0-0037507158 10.1007/s00702-002-0810-8 (Pubitemid 36683520)
51. Li X., Zhu W., Roh M.-S., Friedman A. B., Rosborough K., Jope R. S., In vivo regulation of glycogen synthase kinase-3 β (GSK3 β) by serotonergic activity in mouse brain. Neuropsychopharmacology 2004 29 8 1426 1431 2-s2.0-3242761438 10.1038/sj.npp.1300439 (Pubitemid 38982234)
52. Beaulieu J.-M., Zhang X., Rodriguiz R. M., Sotnikova T. D., Cools M. J., Wetsel W. C., Gainetdinov R. R., Caron M. G., Role of GSK3 β in behavioral abnormalities induced by serotonin deficiency. Proceedings of the National Academy of Sciences of the United States of America 2008 105 4 1333 1338 2-s2.0-39549108481 10.1073/pnas.0711496105 (Pubitemid 351397053)